Hussain Abbas
SEC Form 4 insider trading activity
Hussain Abbas has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: May 4, 2026.
On the most recent filing, Hussain Abbas is listed as Director at Moderna, Inc. Inside the rolling window, Hussain Abbas reported no open-market purchases and 2 open-market sales totaling $279K in MRNA. The largest disclosed transaction in the window is a sale of 5,682 MRNA shares on May 1, 2026, worth $265K.
Companies traded
Other insiders at MRNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$279K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hussain Abbas made?
Hussain Abbas has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Hussain Abbas trade?
Hussain Abbas has filed SEC Form 4 disclosures for 1 company, including MRNA.
When was Hussain Abbas's most recent SEC Form 4 filing?
Hussain Abbas's most recent SEC Form 4 filing on Tracefour is dated May 4, 2026.
What is Hussain Abbas's total buy and sell value in the current window?
Inside the rolling retention window, Hussain Abbas bought $0 and sold $279K based on SEC Form 4 filings.
What was Hussain Abbas's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,682 MRNA shares on 2026-05-01, worth $265K, per SEC Form 4 filings.